The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer. - Wang Q; Zhang M; Zhu QY; Zeng H; Dai JD; Huang K; Wan SC; Shi YF; Zhang XM; Shen PF (Asian journal of andrology, 2026)